Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis

References

1. 1.↵
   1. Grassiot B,
   2. Desgranges B,
   3. Eustache F,
   4. et al

   . Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009;256:1397–412

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Rudick RA,
   2. Fisher E,
   3. Lee JC,
   4. et al

   . Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698–704

   CrossRef
3. 3.↵
   1. Kassubek J,
   2. Tumani H,
   3. Ecker D,
   4. et al

   . Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. Neuroreport 2003;14:427–30

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Sharma J,
   2. Sanfilipo MP,
   3. Benedict RH,
   4. et al

   . Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. AJNR Am J Neuroradiol 2004;25:985–96

   Abstract/FREE Full Text
5. 5.↵
   1. Bermel RA,
   2. Sharma J,
   3. Tjoa CW,
   4. et al

   . A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003;208:57–65

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Chard DT,
   2. Griffin CM,
   3. Parker GJ,
   4. et al

   . Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327–37

   Abstract/FREE Full Text
7. 7.↵
   1. Bermel RA,
   2. Bakshi R

   . The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158–70

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Miller DH,
   2. Barkhof F,
   3. Frank JA,
   4. et al

   . Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95

   Abstract/FREE Full Text
9. 9.↵
   1. Jovicich J,
   2. Czanner S,
   3. Han X,
   4. et al

   . MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177–92

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Riederer SJ,
    2. Lee JN,
    3. Farzaneh F,
    4. et al

    . Magnetic resonance image synthesis. Clinical implementation. Acta Radiol Suppl 1986;369:466–68

    PubMed
11. 11.↵
    1. Bobman SA,
    2. Riederer SJ,
    3. Lee JN,
    4. et al

    . Cerebral magnetic resonance image synthesis. AJNR Am J Neuroradiol 1985;6:265–69

    Abstract/FREE Full Text
12. 12.↵
    1. Redpath TW,
    2. Smith FW,
    3. Hutchison JM

    . Magnetic resonance image synthesis from an interleaved saturation recovery/inversion recovery sequence. Br J Radiol 1988;61:619–24

    Abstract/FREE Full Text
13. 13.↵
    1. West J,
    2. Warntjes JB,
    3. Lundberg P

    . Novel whole brain segmentation and volume estimation using quantitative MRI. Eur Radiol 2012;22:998–07

    CrossRefPubMed
14. 14.↵
    1. Alfano B,
    2. Brunetti A,
    3. Arpaia M,
    4. et al

    . Multiparametric display of spin-echo data from MR studies of brain. J Magn Reson Imaging 1995;5:217–25

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Alfano B,
    2. Brunetti A,
    3. Covelli EM,
    4. et al

    . Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med 1997;37:84–93

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Alfano B,
    2. Brunetti A,
    3. Larobina M,
    4. et al

    . Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis. J Magn Reson Imaging 2000;12:799–807

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Warntjes JB,
    2. Leinhard OD,
    3. West J,
    4. et al

    . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29

    CrossRefPubMed
18. 18.↵
    1. Ambarki K,
    2. Lindqvist T,
    3. Wåhlin A,
    4. et al

    . Evaluation of automatic measurement of the intracranial volume based on quantitative MR imaging. AJNR Am J Neuroradiol 2012;33:1951–56

    Abstract/FREE Full Text
19. 19.↵
    1. Ambarki K,
    2. Israelsson H,
    3. Wahlin A,
    4. et al

    . Brain ventricular size in healthy elderly: comparison between Evans index and volume measurement. Neurosurgery 2010;67:94–99

    CrossRefPubMed
20. 20.↵
    1. Ambarki K,
    2. Wahlin A,
    3. Birgander R,
    4. et al

    . MR imaging of brain volumes: evaluation of a fully automatic software. AJNR Am J Neuroradiol 2011;32:408–12

    Abstract/FREE Full Text
21. 21.↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B,
    4. et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Altman DG,
    2. Bland JM

    . Measurement in medicine: the analysis of method comparison studies. Statistician 1983;32:307–17

    CrossRefWeb of Science
23. 23.↵
    1. Vrenken H,
    2. Geurts JJ,
    3. Knol DL,
    4. et al

    . Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 2006;240:811–20

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Ge Y,
    2. Grossman RI,
    3. Udupa JK,
    4. et al

    . Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000;214:665–70

    PubMedWeb of Science
25. 25.↵
    1. Zivadinov R,
    2. Grop A,
    3. Sharma J,
    4. et al

    . Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. J Neuroimaging 2005;15:27–36

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Horsfield MA,
    2. Rovaris M,
    3. Rocca MA,
    4. et al

    . Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003;216:169–77

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Smith SM,
    2. Zhang Y,
    3. Jenkinson M,
    4. et al

    . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Reed GF,
    2. Lynn F,
    3. Meade BD

    . Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002;9:1235–39

    CrossRefPubMed
29. 29.↵
    1. Battaglini M,
    2. Jenkinson M,
    3. De Stefano N

    . Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2011; 33:2062–71

    PubMed
30. 30.↵
    1. Chard DT,
    2. Jackson JS,
    3. Miller DH,
    4. et al

    . Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010;32:223–28

    CrossRefPubMed